<div id="readability-page-1">11:11 AM EST, 02/20/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts edged up 0.1% to 1,845.20 on the S&amp;P Europe Select ADR Index late Friday morning. It was up 1.76% for the week.From continental Europe, the gainers were led by semiconductor firm Sequans Communications ( SQNS ) and biopharmaceutical company DBV Technologies ( DBVT ) , which rose 2.4% and 2% respectively. They were followed by lender ING (ING) and software firm SAP (SAP), which rose 1.7% and 1.5% respectively.The decliners from continental Europe were led by Ascendis Pharma ( ASND ) and 3D printer company Materialise (MTLS), which fell 2.8% and 2.5% respectively. They were followed by pharmaceutical firm Novo Nordisk ( NVO ) , which was down 2.4%.From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo ( DEO ) and Endava ( DAVA ) , which advanced 3.6% and 3.4% respectively. They were followed by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which were up 3.1% and 2.1% respectively.The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals ( BDRX ) and Trinity Biotech ( TRIB ) , which dropped 7% and 3.1% respectively. They were followed by Bicycle Therapeutics ( BCYC ) , which lost 2%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

SQNS

DAVA

DBVT

SPEU

TRIB

BDRX

ASND

MTLS

European equities traded in the US saw a slight increase, with the S&P Europe Select ADR Index rising 0.1% to 1,845.20, marking a 1.76% gain for the week. Notable gainers included Sequans Communications and DBV Technologies, while Ascendis Pharma and Materialise were among the decliners. In the UK and Ireland, Diageo and Endava led the gains, whereas Biodexa Pharmaceuticals and Trinity Biotech experienced significant declines. MT Newswires does not provide investment advice.

fidelity

Sequans Comm 

Endava

Diageo

DBV Tech

SPDR Portfolio Europe ETF

Trinity Biotech

Biodexa Pharmaceuticals

Ascendis Pharmac

Materialise

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday trading